Subscribe
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo IMG
HOME > MULTIMEDIA > Multimedia Detail

SCIENCE IN THE NEWS DAILY

New Take on a Prostate Drug, and a New Debate

from the New York Times (Registration Required)

For the first time, leading prostate cancer specialists say, they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent.

But the discovery, arising from a new analysis of a large federal study, comes with a debate: Should men take the drug?

Prostate cancer is unlike any other because it is relatively slow-growing, and while it can kill, it often is not lethal. In fact, most leading specialists say, a major problem is that men are getting screened, discovering they have cancers that may or may not be dangerous, and opting for treatments that can leave them impotent or incontinent.

Read more...


comments powered by Disqus
 

Connect With Us:

Facebook Icon Sm Twitter Icon Google+ Icon Pinterest Icon RSS Feed Instagram Icon

Latest Multimedia

CarrollPodcastPODCAST: Compounds Treat Substance Abuse and Parkinson's Disease

Dr. F. Ivy Carroll studies treatments for cocaine abuse, as well as a potential diagnostic agent for Parkinson’s disease, which includes two compounds called RTI-336 and JDTic.

To view all multimedia content, click "Latest Multimedia"!



RSS Feed Subscription

Receive notification when new content is posted from the entire website, or choose from the customized feeds available.


EMAIL TO A FRIEND :

Subscribe to American Scientist